The neoadjuvant esophageal score: a prognostic tool for predicting survival and postoperative complications in esophageal squamous cell carcinoma
The NAE score is a robust prognostic tool for patients with locally advanced ESCC, capable of predicting survival, guiding adjuvant therapy, and estimating risk of severe postoperative complications. Its integration into clinical practice could refine risk stratification and support personalized treatment strategies, with prospective validation warranted.
Authors
- Yuxing Lin
- C. Xu
- Xuan Huang (ORCID: https://orcid.org/0000-0003-0283-1791)
- Cheng Huang (ORCID: https://orcid.org/0000-0003-0704-2943)
- Li Cheng
- Qichang Xie
- Renjie Huang
- Chun Chen
- Zhang Yang
- Hao Chen
- Bin Zheng
Institutions
- Fujian Medical University (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Fuzhou Second Hospital (CN)
- Fuzhou Pulmonary Hospital of Fujian (CN)
- 175th Hospital of People's Liberation Army (CN)
- Fujian Provincial Hospital (CN)
- Fujian Provincial Cancer Hospital (CN)
- Zhangzhou Vocational and Technical College (CN)
- Union Hospital (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-02
- DOI
- https://doi.org/10.3389/fimmu.2025.1706548
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fujian Medical University